The purpose of this study is to assess the efficacy, safety and tolerability of a combination of Vestipitant and Paroxetine in patients with Social Anxiety Disorder (SAD)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
204
GSK Investigational Site
Hilleroed, Denmark
GSK Investigational Site
Hvidovre, Denmark
GSK Investigational Site
Koebenhavn K, Denmark
Change in score on a Social Anxiety Disorder rating scale following 12 weeks of treatment.
Change in score on a number of rating scales following 12 weeks of treatment assessing symptomatic, behavioural and functional parameters which together provide a more complete description of the disorder.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
GSK Investigational Site
Koebenhavn OE, Denmark
GSK Investigational Site
Risskov, Denmark
GSK Investigational Site
Skanderborg, Denmark
GSK Investigational Site
Soroe, Denmark
GSK Investigational Site
Hüttenberg, Hesse, Germany
GSK Investigational Site
Achim, Lower Saxony, Germany
GSK Investigational Site
Berlin, State of Berlin, Germany
...and 7 more locations